5.1 Acute Kidney Injury & KDIGO Staging
Key Takeaways
Acute Kidney Injury (AKI) is diagnosed and staged using KDIGO criteria based on acute rises in serum creatinine (≥26.5 µmol/L within 48h or ≥1.5-fold increase within 7 days) and/or sustained reductions in hourly urine output (<0.5 mL/kg/h for ≥6h).
Aetiology is classified into pre-renal (hypoperfusion: volume depletion, sepsis, heart failure; urine Na <20 mmol/L, FeNa <1%), intrinsic renal (ATN, AIN, glomerulonephritis, rhabdomyolysis; urine Na >40 mmol/L, FeNa >2%), and post-renal (urinary obstruction; requires urgent renal ultrasound within 24h).
Initial management centers on rapid cessation of nephrotoxic medications using the DAMN mnemonic (Diuretics, ACEi/ARBs, Metformin, NSAIDs), cautious balanced crystalloid fluid resuscitation for hypovolaemia, and urinary catheterisation for retention or hourly monitoring.
Emergency indications for Renal Replacement Therapy (RRT / dialysis) follow the AEIOU mnemonic: refractory Acidosis (pH <7.15), refractory Electrolyte disturbances (hyperkalaemia >6.5 mmol/L), toxic Ingestions (salicylates, toxic alcohols, lithium), fluid Overload (pulmonary oedema), and severe Uraemic complications (pericarditis, encephalopathy).
Acute Kidney Injury & KDIGO Staging
Acute Kidney Injury (AKI) represents an abrupt, potentially reversible decline in renal excretory function occurring over hours to days. It leads to the rapid retention of nitrogenous waste products (urea and creatinine), loss of electrolyte and acid-base homeostasis, and dysregulation of intravascular fluid volume. In the National Health Service (NHS), AKI complicates approximately 15–20% of all emergency hospital admissions and is associated with substantial in-hospital morbidity and mortality.
1. Diagnostic Definition & KDIGO Staging Criteria
According to the internationally endorsed Kidney Disease: Improving Global Outcomes (KDIGO) consensus guidelines (adopted by UK NICE Guideline NG148), AKI is diagnosed if any one of the following criteria is fulfilled:
- A rise in serum creatinine by ≥ 26.5 µmol/L within 48 hours, OR
- A rise in serum creatinine to ≥ 1.5 times baseline, known or presumed to have occurred within the prior 7 days, OR
- A documented urine output of < 0.5 mL/kg/hour for at least 6 consecutive hours.
Staging Severity
Once diagnosed, AKI is stratified into three clinical stages according to the magnitude of serum creatinine elevation or the duration and severity of oliguria. When creatinine and urine output yield discordant stages, the higher (more severe) stage is always assigned.
| KDIGO Stage | Serum Creatinine Criteria | Urine Output Criteria |
|---|---|---|
| Stage 1 | Creatinine 1.5–1.9 times baseline OR an absolute increase of ≥ 26.5 µmol/L within 48 hours | < 0.5 mL/kg/hour for 6–12 hours |
| Stage 2 | Creatinine 2.0–2.9 times baseline | < 0.5 mL/kg/hour for ≥ 12 hours |
| Stage 3 | Creatinine ≥ 3.0 times baseline OR increase to ≥ 354 µmol/L OR initiation of Renal Replacement Therapy (RRT) | < 0.3 mL/kg/hour for ≥ 24 hours OR anuria for ≥ 12 hours |
Note
Determining Baseline Creatinine: NHS laboratories in England run the national NHS England AKI detection algorithm on every creatinine result: the reference value is the lowest creatinine in the previous 0–7 days, or, if there is none, the median of results from 8–365 days earlier. A ratio of 1.5 or more generates an AKI warning stage. If no previous result exists, compare with repeat results over the next days (KDIGO also suggests estimating a baseline from an assumed eGFR of 75 mL/min/1.73m²).
2. Aetiological Classification & Diagnostic Differentiation
AKI is mechanistically divided into three anatomical categories: pre-renal, intrinsic renal, and post-renal.
A. Pre-Renal Azotaemia (Renal Hypoperfusion)
Pre-renal AKI accounts for 60–70% of community-acquired cases. It is caused by reduced effective renal arterial perfusion without structural parenchymal damage. If hypoperfusion is rapidly reversed, glomerular filtration rate (GFR) normalises promptly.
- Absolute Hypovolaemia: Haemorrhage, gastrointestinal fluid loss (severe vomiting, choleraic diarrhoea), excessive diuresis, burns, severe dehydration.
- Relative Hypovolaemia / Vasodilation: Sepsis, anaphylaxis, neurogenic shock, liver cirrhosis with splanchnic arterial vasodilation.
- Cardiogenic Pump Failure: Severe acute decompensated heart failure, cardiogenic shock, massive acute myocardial infarction.
- Renal Haemodynamic Impairment: Bilateral renal artery stenosis (or unilateral stenosis in a solitary kidney); concurrent administration of ACE inhibitors or Angiotensin Receptor Blockers (which block angiotensin II-mediated efferent arteriolar vasoconstriction) combined with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs, which block prostaglandin-mediated afferent arteriolar vasodilation).
B. Intrinsic Renal AKI (Structural Parenchymal Injury)
Intrinsic AKI involves acute structural damage to the glomeruli, tubules, interstitium, or renal microvasculature:
- Acute Tubular Necrosis (ATN): The most common cause of intrinsic AKI in hospitalised patients. Occurs secondary to prolonged, uncorrected renal ischaemia (severe shock, prolonged pre-renal state) or direct nephrotoxic exposure (exogenous toxins: aminoglycosides such as gentamicin, iodinated radiocontrast agents, amphotericin B, cisplatin; endogenous toxins: myoglobin in rhabdomyolysis, hemoglobin in massive intravascular haemolysis, light chains in multiple myeloma).
- Acute Interstitial Nephritis (AIN): An immunologically mediated hypersensitivity reaction affecting the renal interstitium. Over 75% of cases are drug-induced, classically triggered by antibiotics (penicillins, cephalosporins, ciprofloxacin, rifampicin), Proton Pump Inhibitors (omeprazole, lansoprazole), NSAIDs, or allopurinol. Autoimmune causes include sarcoidosis, Sjögren's syndrome, and systemic lupus erythematosus (SLE). The classic clinical triad of fever, maculopapular rash, and peripheral eosinophilia is present in only 10–15% of patients (arthralgia may also occur), but urinalysis characteristically demonstrates sterile pyuria, white blood cell casts, and urinary eosinophils.
- Acute Glomerulonephritis: Post-streptococcal GN, IgA nephropathy, ANCA-associated vasculitis (granulomatosis with polyangiitis), anti-GBM disease. Characterised by dysmorphic red cells, red cell casts, proteinuria, and active urinary sediment.
- Rhabdomyolysis: Massive skeletal muscle necrosis releasing toxic myoglobin into the circulation. Classic causes include trauma, crush injuries, prolonged immobility ("long lie" after a fall in elderly individuals), grand mal seizures, severe exertion, hypothermia, and statin-fibrate interactions. Urinalysis demonstrates a strongly positive dipstick for blood in the complete absence of red blood cells on microscopy (because the reagent strip orthotolidine reaction detects the heme moiety of myoglobin). Serum creatine kinase (CK) is markedly elevated (typically > 10,000 U/L, often > 50,000 U/L). Associated electrolyte disturbances include hyperkalaemia, hyperphosphataemia, hyperuricaemia, and early hypocalcaemia (due to calcium precipitation in necrotic myocytes).
C. Post-Renal AKI (Obstructive Uropathy)
Occurs when acute mechanical obstruction to urinary outflow elevates retrograde hydrostatic pressures within Bowman's space, opposing glomerular filtration:
- Bladder Outflow Obstruction: Benign Prostatic Hyperplasia (BPH), prostate adenocarcinoma, blocked urethral catheter, neurogenic bladder, urethral strictures.
- Ureteric Obstruction: Bilateral ureteric calculi (or unilateral calculus in a single functional kidney), retroperitoneal fibrosis, retroperitoneal lymphadenopathy, pelvic malignancies (cervical, colorectal, or ovarian carcinoma).
- Diagnostic Investigation: Urgent renal tract ultrasound must be performed within 24 hours of presentation (or within 6 hours in suspected pyonephrosis, sepsis, or solitary kidney) to identify pelvicalyceal dilatation (hydronephrosis and hydroureter).
3. Pre-Renal Azotaemia vs. Acute Tubular Necrosis (ATN)
Distinguishing pre-renal hypoperfusion from established ATN is critical because pre-renal failure responds rapidly to fluid resuscitation, whereas established ATN carries a damaged tubular epithelium that cannot concentrate urine or reabsorb sodium, placing the patient at high risk of fluid overload if excessive fluids are given.
| Diagnostic Parameter | Pre-Renal Azotaemia | Acute Tubular Necrosis (ATN) |
|---|---|---|
| Pathophysiological State | Intact tubular function; avid sodium & water reabsorption | Damaged, necrotic tubular epithelium; impaired reabsorption |
| Urinary Sodium (Na) | < 20 mmol/L (avid conservation) | > 40 mmol/L (tubular salt wasting) |
| Fractional Excretion of Sodium (FeNa) | < 1% | > 2% |
| Fractional Excretion of Urea (FeUrea) | < 35% (useful if patient takes diuretics) | > 50% |
| Urine Osmolality | > 500 mOsm/kg (concentrated urine) | < 350 mOsm/kg (isosthenuric; matches plasma) |
| Urine : Plasma Urea Ratio | > 10 : 1 | < 4 : 1 |
| Urine : Plasma Creatinine Ratio | > 40 : 1 | < 20 : 1 |
| Urinary Microscopy | Normal OR hyaline casts | Muddy brown granular casts, tubular epithelial cell casts |
| Response to IV Fluid Challenge | Rapid urine output rise & creatinine clearance | Minimal or no immediate biochemical improvement |
4. Acute Clinical Management Protocol
Management of AKI follows a structured, evidence-based algorithm:
Step 1: Medication Review & Cessation of Nephrotoxins (DAMN Mnemonic)
Immediate discontinuation of all potentially nephrotoxic or renally cleared agents is mandatory. Remember the DAMN mnemonic:
- D – Diuretics: Furosemide, bumetanide, indapamide, spironolactone (withhold immediately unless pulmonary oedema is present).
- A – ACE inhibitors / ARBs: Ramipril, lisinopril, losartan, candesartan (withhold; their efferent arteriolar vasodilation lowers glomerular filtration pressure, which worsens GFR when renal perfusion is already reduced).
- M – Metformin: Withhold immediately! Metformin is cleared by the kidneys; accumulation during AKI induces life-threatening Metformin-Associated Lactic Acidosis (MALA).
- N – NSAIDs: Ibuprofen, naproxen, diclofenac, meloxicam (stop immediately; inhibits vasodilatory prostaglandins at afferent arterioles).
- Additional agents to stop or dose-adjust: Aminoglycosides (gentamicin), vancomycin, amphotericin, iodinated contrast agents, and direct oral anticoagulants (DOACs).
Step 2: Haemodynamic Assessment & Fluid Resuscitation
- Hypovolaemic AKI: Administer 500 mL boluses of intravenous balanced crystalloid (e.g. Plasma-Lyte 148 or Hartmann's solution) over 15 minutes, followed by clinical reassessment (pulse, blood pressure, capillary refill time, JVP, chest auscultation). Avoid large volumes of 0.9% normal saline, which induce hyperchloraemic metabolic acidosis and renal vasoconstriction.
- Euvolaemic or Hypervolaemic AKI: Fluid boluses are harmful. Restrict maintenance fluid to insensible losses (30–50 mL/h) plus measured urinary output.
Step 3: Urgent Catheterisation & Bladder Decompression
Insert a Foley urinary catheter if urinary retention is suspected, if the patient is haemodynamically unstable, or to enable accurate hourly urine output monitoring in KDIGO Stage 2 or 3 AKI.
5. Emergency Indications for Renal Replacement Therapy: The AEIOU Mnemonic
When conservative medical management fails, urgent nephrology referral for Renal Replacement Therapy (RRT / Haemodialysis) is lifesaving. The emergency indications are memorised using the AEIOU mnemonic:
- A – Acidosis (Metabolic): Severe refractory metabolic acidosis with arterial pH < 7.15 or serum bicarbonate < 10 mmol/L, unresponsive to medical therapy.
- E – Electrolytes (Hyperkalaemia): Refractory hyperkalaemia with serum potassium > 6.5 mmol/L or rapidly rising levels associated with toxic ECG changes, refractory to insulin-dextrose and calcium gluconate.
- I – Ingestions / Toxins: Poisoning with dialysable toxins (mnemonic SLIME: Salicylates, Lithium, Isopropanol, Methanol, Ethylene glycol).
- O – Overload (Fluid): Intractable, diuretic-resistant acute pulmonary oedema causing respiratory failure in an oliguric or anuric patient.
- U – Uraemia (Complications): Life-threatening end-organ uraemic manifestations: uraemic pericarditis (pericardial friction rub, risk of haemorrhagic tamponade), uraemic encephalopathy (confusion, asterixis, myoclonus, seizures, coma), or uraemic bleeding diathesis secondary to platelet dysfunction.
A 74-year-old man admitted with severe septic shock secondary to Escherichia coli urosepsis has a baseline serum creatinine of 85 µmol/L documented two months ago. Following initial resuscitation on the intensive care unit, repeat bloods reveal a serum creatinine of 220 µmol/L. His measured urine output over the preceding 8 hours has averaged 15 mL/hour. His body weight is 70 kg. According to KDIGO guidelines, what is this patient's acute kidney injury stage?
KDIGO Stage 3
KDIGO Stage 1
Does not meet formal criteria for acute kidney injury
KDIGO Stage 2
A 68-year-old woman presents to the acute medical unit with profound dehydration following 4 days of intractable watery diarrhoea. On admission, her blood pressure is 88/54 mmHg, heart rate is 112 bpm, and skin turgor is markedly decreased. Laboratory results reveal serum urea 24.2 mmol/L, serum creatinine 310 µmol/L (baseline 80 µmol/L), urinary sodium 11 mmol/L, fractional excretion of sodium (FeNa) 0.4%, and urine osmolality 640 mOsm/kg. Urinary microscopy demonstrates normal appearance with occasional hyaline casts. What is the primary underlying pathophysiology responsible for her acute renal dysfunction?
Rapidly progressive crescentic glomerulonephritis with podocyte disruption
Pre-renal hypoperfusion leading to compensatory tubular sodium and water retention
Acute tubular necrosis from prolonged renal cortical ischaemic damage
Drug-induced acute interstitial nephritis triggered by antibiotic exposure
A 78-year-old man with severe peripheral vascular disease develops acute kidney injury following an endovascular repair procedure. His baseline serum creatinine was 90 µmol/L; current creatinine is 490 µmol/L. Over the past 12 hours, his total urine output has been 40 mL despite 80 mg of IV furosemide. An arterial blood gas reveals: pH 7.09, pO2 11.2 kPa, pCO2 3.6 kPa, HCO3- 8.0 mmol/L, base excess -19 mmol/L, and serum potassium 7.0 mmol/L. His 12-lead ECG demonstrates broad QRS complexes and tall tented T waves. He is clinically tachypnoeic, and chest auscultation reveals bilateral coarse crackles throughout both lung bases. What is the most appropriate definitive intervention for this patient?
High-dose intravenous bumetanide infusion to initiate diuresis
Intravenous infusion of 500 mL 8.4% sodium bicarbonate solution
Emergency renal replacement therapy / haemodialysis
Subcutaneous injection of recombinant human erythropoietin
Sections you finish are checked off in the contents.